Biotech · Private company · Missoula, MT, US
Inimmune Corporation
Track this companyFree. Adds Inimmune Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINESFiscal year 2026 · $1.9MNIH RePORTER 75N93023C00042-P00004-9999-1 · fetched Nov 12, 2026
- DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINESFiscal year 2025 · $1.6MNIH RePORTER 75N93023C00042-P00004-9999-1 · fetched Nov 12, 2026
- DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINESFiscal year 2024 · $2.5MNIH RePORTER 75N93023C00042-P00001-9999-1 · fetched Nov 12, 2026